Last reviewed · How we verify

NCT05599698

Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer

Recruiting now NA Last updated 14 May 2024
What this trial tests

NA trial testing Chemotherapy in Cancer in 38 participants. Currently enrolling.

Timeline
15 November 2022
Primary endpoint
30 September 2025
30 December 2025

Quick facts

Lead sponsorBnai Zion Medical Center
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment38
Start date15 November 2022
Primary completion30 September 2025
Estimated completion30 December 2025
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Bnai Zion Medical Center

Who can join

Adults 18 to 75, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine changes in perceived daily performance and executive functioning following chemotherapy in individuals with non-central nervous system cancers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Characterizing changes in executive functions and performance in daily activities after chemotherapy: A pre-post mixed-methods study protocol.
    Loubani K, Rand D, Agbarya A, Agbarya A. · · 2024 · PMID 39671361 · DOI 10.1371/journal.pone.0314551

Verify or expand the search:

Other trials of Chemotherapy

Trials testing the same drug.

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Bnai Zion Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05599698.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing